Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Shen Lian BiomedicalSHSE:688098 -0.73%69 Days Inventory is 404.45 as of Mar. 2026, which is 13% above its 10-year median of 357.88. GuruFocus rates SHSE:688098 with a GF Score™ of 69/100 and a GF Value™ of ¥5.86 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 638 Biotechnology companies, Shanghai Shen Lian Biomedical ranks worse than 68.34% on this metric.
The historical rank and industry rank for Shanghai Shen Lian Biomedical's Days Inventory or its related term are showing as below:
SHSE:688098'
s Days Inventory Range Over the Past 10 Years
Min: 277.96 Med: 357.88 Max: 490.46
Current: 300.95
During the past 13 years, Shanghai Shen Lian Biomedical's highest Days Inventory was 490.46. The lowest was 277.96. And the median was 357.88.
SHSE:688098's Days Inventory is ranked worse than 68.34% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:688098: 300.95
Inventory Turnover measures how fast the company turns over its inventory within a year.
Shanghai Shen Lian Biomedical's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.23.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Shanghai Shen Lian Biomedical's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.63.
Shanghai Shen Lian Biomedical (SHSE:688098) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Shanghai Shen Lian Biomedical's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Shanghai Shen Lian Biomedical's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Shanghai Shen Lian Biomedical Days Inventory Related Terms
Shanghai Shen Lian Biomedical Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shen Lian Biomedical Days Inventory Chart
SHSE:688098 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Shanghai Shen Lian Biomedical's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Shen Lian Biomedical Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Shen Lian Biomedical's Days Inventory distribution charts can be found below:
* The bar in red indicates where Shanghai Shen Lian Biomedical's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Shen Lian Biomedical (SHSE:688098) has a Days Inventory of 404.45 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Shanghai Shen Lian Biomedical and its competitors. This is 13% above median its historical median of 357.88. Over the past decade, Shanghai Shen Lian Biomedical's Days Inventory has ranged from 277.96 to 490.46. According to the industry distribution chart, Shanghai Shen Lian Biomedical ranks #436 out of 638 companies in the Biotechnology industry, placing it in the top 68.3%.
Is Shanghai Shen Lian Biomedical's Days Inventory too high?
Shanghai Shen Lian Biomedical's current Days Inventory of 404.45 is 13% above median its 10-year median of 357.88. Over the past 10 years, this metric has ranged from a low of 277.96 to a high of 490.46. The Biotechnology industry median Days Inventory is 183.20. Shanghai Shen Lian Biomedical's value of 404.45 is 120.8% above this industry median. Based on the distribution chart, Shanghai Shen Lian Biomedical ranks #436 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shanghai Shen Lian Biomedical has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Shen Lian Biomedical's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Shen Lian Biomedical ranks #436 out of 638 companies for Days Inventory. This places Shanghai Shen Lian Biomedical in the lower half of its industry. The industry median Days Inventory is 183.20. Shanghai Shen Lian Biomedical's value of 404.45 is 120.8% above this benchmark. Historically, Shanghai Shen Lian Biomedical's own Days Inventory has ranged from 277.96 to 490.46 over the past decade. While the company's 10-year median is 357.88 vs. the industry median of 183.20, Shanghai Shen Lian Biomedical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Shen Lian Biomedical's current Days Inventory of 404.45 is 120.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Shanghai Shen Lian Biomedical and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Shen Lian Biomedical's current Days Inventory is 404.45, which is 13% above median its own 10-year median of 357.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Shen Lian Biomedical stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical (SHSE:688098) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥5.86, compared to a current price of ¥8.21 — trading 40.1% above its estimated fair value. The current Days Inventory is 404.45, which is 13% above median its 10-year median of 357.88 and 120.8% above the Biotechnology industry median of 183.20. Shanghai Shen Lian Biomedical's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Shanghai Shen Lian Biomedical (SHSE:688098), the current Days Inventory is 404.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Shen Lian Biomedical (SHSE:688098) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Shen Lian Biomedical stock appears to be overvalued.
The current stock price of ¥8.21 is trading 40.1% above its estimated GF Value™ of ¥5.86.
GuruFocus considers Shanghai Shen Lian Biomedical to be Significantly Overvalued.
Key valuation signals for SHSE:688098:
Days Inventory: 404.45 (13% above median its 10-year median of 357.88)
GF Value™: ¥5.86 vs. price of ¥8.21 (40.1% above fair value)
Industry Position: 120.8% above the Biotechnology median (#436 of 638)
No single metric tells the full story. See the SHSE:688098 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Shen Lian Biomedical Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688098 has been successfully added to your 
